Gentaur Epcoritamab – Anti-CD3E / CD20 (MS4A1) Bispecific
Bridges T-cells to B-cells by binding CD3E and CD20, driving targeted B-cell depletion. Ideal for lymphoma and immunotherapy models.
Internal Reference:
GMA-CD3E
Display Name:
[GMA-CD3E] Gentaur Epcoritamab – Anti-CD3E / CD20 (MS4A1) Bispecific